Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

The leukemia inhibitory factor (LIF).

¹Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.

International Journal of Cell Cloning

|March 1, 1991

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The SOCS box of suppressor of cytokine signaling-1 is important for inhibition of cytokine action in vivo.

Proceedings of the National Academy of Sciences of the United States of America·2001

Same author

Production of colony-stimulating factors and IL-5 by organs from three types of mice with inflammatory disease due to loss of the suppressor of cytokine signaling-1.

Journal of immunology (Baltimore, Md. : 1950)·2001

Same author

Neutralization of interferon-gamma in neonatal SOCS1-/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease.

Immunology·2001

Same author

Functional analysis of Asb-1 using genetic modification in mice.

Molecular and cellular biology·2001

Same author

The multi-organ origin of interleukin-5 in the mouse.

Leukemia·2001

Same author

Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3.

Proceedings of the National Academy of Sciences of the United States of America·2001

Same journal

Pharmacologic validation of human tumor clonogenic assays based on pleiotropic drug resistance: implications for individualized chemotherapy and new drug screening programs.

International journal of cell cloning·1992

Same journal

Cloning of human tumor cell lines in porous glass capillary tubes: a further development of the human tumor stem cell assay.

International journal of cell cloning·1992

Same journal

An in vitro thymidine incorporation assay for human cancers: technical details revisited.

International journal of cell cloning·1992

Same journal

Peripheral blood hematopoietic progenitor cells in beta-thalassemia major.

International journal of cell cloning·1992

Same journal

Serum erythropoietin titers in hematological malignancies and related diseases.

International journal of cell cloning·1992

Same journal

Viral involvement in Hodgkin's disease.

International journal of cell cloning·1992

See all related articles

Leukemia inhibitory factor (LIF) regulates cell differentiation and self-renewal in various cell types. This glycoprotein shows promise for treating myeloid leukemia and thrombocytopenia.

Area of Science:

Biochemistry
Cell Biology
Hematology

Background:

Leukemia inhibitory factor (LIF) is a glycoprotein with diverse cellular functions.
LIF influences myeloid leukemic cell lines by promoting differentiation and suppressing self-renewal.
In normal embryonic stem cells, LIF inhibits differentiation.

Purpose of the Study:

To investigate the multifaceted roles of LIF in cellular regulation.
To explore LIF's potential in treating hematological disorders.

Main Methods:

Analysis of LIF's effects on myeloid leukemic cell lines.
Assessment of LIF's impact on normal embryonic stem cells and hemopoietic cells.
In vivo studies to evaluate LIF's effects on megakaryocyte and platelet levels.

Related Experiment Videos

Main Results:

LIF enforces differentiation and suppresses self-renewal in myeloid leukemic cells.
LIF prevents differentiation in normal embryonic stem cells.
LIF potentiates interleukin-3 effects on hemopoietic precursors and increases platelet counts in vivo.
LIF impacts various other cell types, including hepatic, neuronal, and gonadal cells.

Conclusions:

LIF is a polyfunctional regulator, likely acting locally.
LIF demonstrates potential for clinical applications in thrombocytopenia and myeloid leukemia.